Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples